Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-24T18:31:59.509Z Has data issue: false hasContentIssue false
  • English
  • Français

Serratia marcescens Infections

Published online by Cambridge University Press:  02 January 2015

Jacques F. Acar
Jacques F. Acar*
Affiliation:
Á L'hôpital Saint-joseph, Universite Pierre & Marie Curie, Paris, France
*
Biologiste des hopitaus, Professeur de Microbiologie Medicale, Universite Pierre & Marie Curie, 7, rue Pierre-Larousse, 75674 PARIS CEDEX 14, Pans, France
Get access Rights & Permissions [Opens in a new window]

Extract

The recognition of serratia as an opportunistic human pathogen can be dated from 1959, when the microorganism entered the family of Enterobacteriaceae, with features recognizable in the clinical laboratory and related to the Klebsiella/Enterobacter group. Since then, physicians have been challenged to establish the significance of isolation of serratia from a clinical specimen.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 7 , Issue 5 , May 1986 , pp. 273 - 280
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Yu, VL, Serratia marcescens. Historical perspective and clinical review N Engl J Med 1979;300:887–893.Google Scholar
2.Robinson, W, Woolley, PB, Pseudohaemoptysis due to Chromobacterium pro-digiosum. Lancet 1957;1:819.Google Scholar
3.Waisman, HA, Stone, WH, The presence of Serratia marcescens as the predominating organism in the intestinal tract of the newborn: The occurrence of the “red diaper syndrome” Pediatrics 1958;21:8–12.Google Scholar
4.Gumming, JG, Sputum-borne disease transmission with epidemiologic and bactériologie research. Milit Surg 1920;46:150–165.Google Scholar
5.McEntengart, MG, Porterheld 1S, Bacteremia following dental extractions. Lancet 1949;2:596–602.CrossRefGoogle Scholar
6.Kass, EH, Schneidermman, LJ, Entry of bacteria into the urinary tracts of patients with inlying catheters. N Engl J Med 1957;256:556–557.Google Scholar
7.Farmer, JJ III, Davis, BR, Grimont, PAD, et al: Source of American Serratia. Lancet 1977;2:459–460.Google Scholar
8.Simberkoff, MS, Ricupero, I, Rahal, JJ Jr: Host resistance to Seiratia marcescens infections serum bactericidal activity and phagocytosis by normal blood leukocytes. J Lab Clin Med 1976;87:206.Google Scholar
9.Traub, WH, Further studies on the susceptibility of Seiratia marcescens to the bactericidal activity of human serum: Resistance of isolates against serum transferring-mediated iron deprivation and chelation of cations by EDTA Exp Cell Biol 1977;45:184.Google Scholar
10.Weinberg, ED, Iron and infection. Microbiol Rev 1978;42:45.Google Scholar
11.Grimont, PAD, Grimont, F, Taxonomie des Serratia. Inserrn 1983;114:129–142.Google Scholar
12.Meers, PD, Ayliffe, GA, Emmerson, AM, et al: Report on the national survey of infection in hospitals 1980. J Hosp Infect 1981;2(Suppl).Google Scholar
13.Von Graevenitz, A, Rubin, SJ, Infection and colonization with Serratia, in Von Graevenitz, A, Rubin, SJ (eds): The Genus Serratia. Boca Raton, CRC Press, 1980:167–186.Google Scholar
14.Krieger, JN, Levy Zombek, E, Scheidt, A, Nosocomial epidemic of antibiotic-resistant Serratia marcescens urinary tract infections. J Urol 1980;124:498–502.CrossRefGoogle ScholarPubMed
15.Maki, DG, Hennekens, CG, Phillips, CW, et al: Nosocomial urinary tract infection with Serratia marcescens: An epidemiological study. J Infect Dis 1973;128:579.CrossRefGoogle Scholar
16.Schaberg, DR, Alford, RH, Anderson, R, et al: An outbreak of nosocomial infection due to multiply resistant Serratia marcescens; Evidence of inter-hospital spread. J Infect Dis 1976;134:181.CrossRefGoogle Scholar
17.Vic-Dupont, V, Witchitz, S, Emile, J, et al: Bactériémies et septicémies à Serratia marcescens. A propos de 50 hémocultures positives (26 malades). Ann Intern Med 1969;120:395.Google Scholar
18.Meltz, DJ, Grieco, MH, Characteristics of Serratia marcescens pneumonia. Arch Intern Med 1973;132:359.Google Scholar
19.Carlon, GC, Dickinson, PCT, Goldiner, PL, et al: Serratia marcescens pneumonia. Ann Surg 1977;112:1220.Google Scholar
20.Bodey, GP, Rodriguez, V, Smith, JP, Serratia sp. infections in cancer patients. Cancer 1970;25:199.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
21.Wilfert, JN, Barrett, FF, Kass, EH, Bacteremia due to Serratia marcescens. N Engl J Med 1968;279:286.CrossRefGoogle ScholarPubMed
22.Alexander, RH, Reichenbach, DD, Merendino, KA, Serratia marcescens endocarditis, A review of the literature and report of a case involving a homograft replacement of the aortic valve. Arch Surg 1969;98:287.CrossRefGoogle ScholarPubMed
23.Lass, JH, Haaf, J, Foster, C, et al: Visual outcome in eight cases of Serratia marcescens keratitis. Am J Ophthalmol 1981;92:384–390.Google Scholar
24.Smith, PJ, Brookfield, DSK, Shaw, DA, et al: An outbreak of Serratia marcescens infection in a neonatal unit. Lancet 1984;21:151.CrossRefGoogle Scholar
25.Baker, CJ: Nosocomial septicemia and meningitis in neonates. Am J Med 1981;70:698–701.Google Scholar
26.Graevenitz, Von, Rubin, SJ, Biotyping, serotyping, Zymotyping and anti-biogram typing of Serratia marcescens in, Von Graeventiz, A, Rubin, SJ (eds): The Genus Serratia. Boca Raton, CRC Press 1980;101–120.Google Scholar
27.Murray, PR, Standardization of the Analytab Enteric (API 20E) System to increase accuracy and reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol 1978;8:46.CrossRefGoogle ScholarPubMed
28.Grimont, PAD, Grimont, F, Proteinase zymograms of Serratia marcescens as an epidemiological tool. Current Microbiology 1978;1:15.CrossRefGoogle Scholar
29.Grimont, AP, Grimont, F, Biotyping of Serratia marcescens and its use in epidemiological studies. J Clin Microbiol 1978;8:73.CrossRefGoogle ScholarPubMed
30.Grimont, PAD, Grimont, F, Le Minor, S, et al: Compatible results obtained from biotying and serotying in Serratia marcescens. J Clin Microbiol 1979;10:425–432.CrossRefGoogle Scholar
31.Rubin, SJ, Brock, S, Chamberland, M.et al: Combined serotyping and biotyping of Serratia marcescens. J Clin Microbiol 1976;3:582.Google Scholar
32.Hamilton, RL, Brown, WJ, Bacteriophage typing of clinically isolated Serratia marcescens. Applied Microbiology 1972;24:899.CrossRefGoogle ScholarPubMed
33.Traub, WH, Raymond, EA, Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing. Applied Microbiology 1971;22:1058.CrossRefGoogle ScholarPubMed
34.Schaefler, S, Winter, J, Catelli, A, et al: Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections. Applied Microbiology 1971;22:339.Google Scholar
35.Farmer, JJ III, Davis, B, Hicman, FW, et al: Detection of Serratia outbreaks in hospital. Lancet 1976;2:455–459.CrossRefGoogle ScholarPubMed
36.McCormack, RC, Kunin, CM: Control of a single source nursery epidemic due to Seiratia marcescens. Pediatrics 1966;37:750–755.Google Scholar
37.Goldmann, DA, Bacterial colonization and infections in neonate. Am J Med 1981;70:417–422.Google Scholar
38.Gordon, D, Christensen, MD, Sheldon, B, et al: Epidemie Serratia marcescens in a neonatal intensive care unit: Importance of the gastrointestinal tract as a reservoir. Infect Control 1982;3:127.Google Scholar
39.Denis, FA, Blanchard, P, Enquête sur les porteurs intestinaux de Serratia. Possibilite d'infections d'origine endogène. Nouv Presse Med 1975; iv:2114.Google Scholar
40.Grimont, PAD, Grimont, F, The genus Seiratia. Annu Rev Microbiol 1978;32:221.Google Scholar
41.Daschner, FD, The epidemiology of Serratia marcescens, in Von Graevenitz, A, Rubin, SJ (eds): The Genus Serratia. Boca Raton: CRC Press, 1980;187–196.Google Scholar
42.Sautter, RL, Mattman, LH, Legaspi, RC, Serratia marcescens meningitis associated with a contaminated benzalkonium chloride solution. Infect Control 1984;5:223.Google Scholar
43.Chabbert, Y, Monnier, J, Courtieu, AL, et al: Colistine. Pathol Biol 1961;9:2123–2125.Google Scholar
44.Annear, DI, Hudson, JA, An unusual zone surrounding Colistin discs in sensitivity tests of Serratia marcescens. Med J Aust 1970; i:840–841.CrossRefGoogle Scholar
45.Farrar, WE Jr: Antimicrobial susceptibility of clinical isolates. Synergistic effects and β lactamases of Serratia, in Von Graevenitz, A, Rubin, J (eds): The Genus Serratia. Boca Raton: CRC Press 1980;121–138Google Scholar
46.Traub, WH, Polymyxin β-Induced Cocarde Growth Phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin β. Chemotherapy 1982;28:363–368.CrossRefGoogle Scholar
47.Medeiros, AA, β Lactamases. Brit Med Bull 1984;40:18–27.Google Scholar
48.O'Brien, TF, Ross, DG, Guzman, MA, et al: Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother 1980;17:537.CrossRefGoogle ScholarPubMed
49.Witchitz, JL, Epidemiological aspects of aminoglycoside resistance in France. J Antimicrob Chemother 1981;8(Suppl a):7l–82.CrossRefGoogle ScholarPubMed
50.Hare, RS, Miller, GH, Mechanisms of aminoglycoside resistance. The Anti-microbic Newsletter 1984;1:77–84.CrossRefGoogle Scholar
51.John, JF jr, McNeill, WF, Price, KE, et al: Evidence for a chromosomal site specifying amikacin resistance in multi-resistant Serratia marcescens. Antimicrob Agents Chemother 1982;21:587–591.CrossRefGoogle Scholar
52.Sanders, CC, Sanders, WE, Richard, JR, et al: Selection of multiple antibiotic resistance by quinolones, lactams and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 1984;26:797–801.Google Scholar
53.Goldstein, FW, Gutmann, L, Williamson, R, et al: In vivo and in vitro emergence of simultaneous resistance to both -lactam and -aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol (Inst. Pasteur) 1983;134A,329–337.Google Scholar
54.Traub, WH, Kleber, I, Selected and spontaneous variants of Serratia marcescens with combined resistance against chloramphenicol, nalidixic acid, and trimethoprim. Chemotherapy 1977;23:436–51.Google Scholar
55.Gutmann, L, Williamson, R, Moreau, N, et al: Cross-resistance to nalidixic acid, trimethoprim and chloramphenicol associated with alterations in outer membrane proteins of klebsiella, enterobacter and Serratia. J Infect Dis 1985;151:501–507.Google Scholar
56.Hedges, RW, R factors of Serratia, in Von Graevenitz, A, Rubin, SJ (eds): The Genus Serratia. Boca Raton: CRC Press 1980;139–153.Google Scholar
57. Le Minor, L, Coynault, C, Schwartz, M: Determination plasmidique du caractere “lactose positif” de Serratia liquefaciens, Ann Microbiol (Paris) 1974;125B,357.Google Scholar
58.Acar, JF, Bouanchaud, DH, Chabbert, YA, Evolutionary aspects of plasmid-mediated resistance in a hospital environment, in Drews, J, Högenauer, G (eds): “R factors: Their Properties and Possible Control”. Topics in Infectious Diseases. New York: Springer-Verlag Wien 1977;2:5–20.CrossRefGoogle Scholar
59.Gerding, DN, Buxton, AE, Hughes, RA, et al: Nosocomial multiply resistant Klebsiella pneumoniae epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother 1979;15:608–615.Google Scholar
60.Rubens, CE, Farrar, WE Jr, McGee, ZA, et al: Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J Infect Dis 1981;143:170.Google Scholar
61.John, JF, McNeill, WF, Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis 1981;143:810.CrossRefGoogle ScholarPubMed
62.Mayer, KH, Hopkins Gilleece, ES, et al: Interspecies mobility, molecular evolution, and clinical consequences of a gentamicin resistance plasmid persisting in one center. J Infect Dis submitted for publication.Google Scholar
63.Hedges, RW, Rodriguez-Lemoine, V, Datta, N, R factors from Serratia marcescens. J Gen Microbiol 1975;86:88.Google Scholar
64.Marrie, TJ, Noble, MA, Haidane, EV, et al: Serratia marcescens, A marker for an infection control program. Infect Control 1982;3:134–142.Google Scholar
65.Baudens, JA, Quangham, Le, Chabbert, YA, Action des polymyxines et de l’acide nalidixique sur les Serratia. Vè Congrès Internat, de chimiothérapie, Vienne 1967;1:99–102.Google Scholar
66.Ostenson, RC, Fields, BT, Nolan, CM, Polymyxin β and rifampin: New regimen for multi-resistant Serratia marcescens infections. Antimicrob Agents Chemother 1977;12:655–659.Google Scholar
67.Thomas, FE, Leonard, JM Jr, Alford, RH, Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother 1976;9:201–207.Google Scholar
68.Collatz, E, Gutmann, L, Williamson, R, et al: Development of resistance to lactam antibiotics with special reference to third-generation cephalosporins. J Antimicrob Chemother 1984;14(Suppl B):13–21.Google Scholar